P.J. de Vos van Steenwijk

van de Sande, A. J. M., van Baars, R., Koeneman, M. M., Gerestein, C. G., Kruse, A.-J., van Esch, E. M. G., de Vos van Steenwijk, P. J., Muntinga, C. L. P., Willemsen, S. P., van Doorn, H. C., van Kemenade, F. J., & van Beekhuizen, H. J. (2025). Topical imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia lesions (TOPIC-2): A randomised controlled trial. Bjog-an International Journal of Obstetrics and Gynaecology, 132(8), 1056-1064. https://doi.org/10.1111/1471-0528.17808

Delahaije, J. J. E., Jerry, E. E., Houterman, S., van Woerkom, A., van Loosdregt, D., Boll, D., Slangen, B. F. M., Bekkers, R. L. M., De Vos van Steenwijk, P. J., de Hullu, J. A., Aarts, A. J. W. M., van Haren, E. L. W. G., & van Esch, E. M. G. (2025). Risk Factors for Wound Complications in Vulvar Cancer Surgery and Indications for Reconstructive Surgery. Cancers, 17(11), Article 1749. https://doi.org/10.3390/cancers17111749

Schellekens, H. C. J., Schmidt, L. M. S., Morre, S. A., van Esch, E. M. G., & van Steenwijk, P. J. D. V. (2025). Vaginal Microbiota and Local Immunity in HPV-Induced High-Grade Cervical Dysplasia: A Narrative Review. International Journal of Molecular Sciences, 26(9), Article 3954. https://doi.org/10.3390/ijms26093954

Jacques, E., van den Bosch, A., van Steenwijk, P. D. V., Kooreman, L., Delvoux, B., Romano, A., & Werner, H. (2024). Pilot Data Suggest That Obesity and Presence of Malignancy Are Associated with Altered Immune Cell Infiltration in Endometrial Biopsies. Journal of Clinical Medicine, 13(23), Article 7248. https://doi.org/10.3390/jcm13237248

van de Sande, A. J. M., Kengsakul, M., Koeneman, M. M., Jozwiak, M., Gerestein, C. G., Kruse, A. J., van Esch, E. M. G., van Steenwijk, P. J. D. V., Muntinga, C. L. P., Bramer, W. M., van Doorn, H. C., van Kemenade, F. J., & van Beekhuizen, H. J. (2024). The efficacy of topical imiquimod in high-grade cervical intraepithelial neoplasia: A systematic review and meta-analysis. International Journal of Gynecology & Obstetrics, 164(1), 66-74. https://doi.org/10.1002/ijgo.14953

Schuurman, T. N., Schaafsma, M., To, K. H., Verhoef, V. M. J., Sikorska, K., Siebers, A. G., Wenzel, H. H. B., Bleeker, M. C. G., Roes, E. M., Zweemer, R. P., de Vos van Steenwijk, P. J., Yigit, R., Beltman, J. J., Zusterzeel, P. L. M., Lok, C. A. R., Bekkers, R. L. M., Mom, C. H., & van Trommel, N. E. (2023). Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort study. The Lancet Oncology, 24(12), 1349-1358. https://doi.org/10.1016/S1470-2045(23)00467-9

Abdulrahman, Z., Hendriks, N., J Kruse, A., Somarakis, A., J M van de Sande, A., J van Beekhuizen, H., M J Piek, J., de Miranda, N. F. C. C., Kooreman, L. F. S., F M Slangen, B., van der Burg, S. H., de Vos van Steenwijk, P. J., & van Esch, E. M. G. (2022). Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions. Journal for ImmunoTherapy of Cancer, 10(11), Article e005288. https://doi.org/10.1136/jitc-2022-005288

Speetjens, F. M., Welters, M. J. P., Slingerland, M., van Poelgeest, M. I. E., de Vos van Steenwijk, P. J., Roozen, I., Boekestijn, S., Loof, N. M., Zom, G. G., Valentijn, A. R. P. M., Krebber, W.-J., Meeuwenoord, N. J., Janssen, C. A. H., Melief, C. J. M., van der Marel, G. A., Filippov, D. V., van der Burg, S. H., Gelderblom, H., & Ossendorp, F. (2022). Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesions. Journal for ImmunoTherapy of Cancer, 10(10), Article e005016. https://doi.org/10.1136/jitc-2022-005016

Hendriks, N., Koeneman, M. M., van de Sande, A. J. M., Penders, C. G. J., Piek, J. M. J., Kooreman, L. F. S., van Kuijk, S. M. J., Hoosemans, L., Sep, S. J. S., de Vos Van Steenwijk, P. J., van Beekhuizen, H. J., Slangen, B. F. M., Nijman, H. W., Kruitwagen, R. F. P. M., & Kruse, A.-J. (2022). Topical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasia (TOPIC-3): A Nonrandomized Multicenter Study. Journal of Immunotherapy, 45(3), 180-186. https://doi.org/10.1097/CJI.0000000000000414

Muntinga, C. L. P., van Steenwijk, P. D. J., Bekkers, R. L. M., & van Esch, E. M. G. (2022). Importance of the Immune Microenvironment in the Spontaneous Regression of Cervical Squamous Intraepithelial Lesions (cSIL) and Implications for Immunotherapy. Journal of Clinical Medicine, 11(5), Article 1432. https://doi.org/10.3390/jcm11051432